Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2012
10/26/2012WO2012089742A3 IDENTIFICATION OF A NOVEL HUMAN POLYOMAVIRUS (IPPyV) AND APPLICATIONS
10/26/2012WO2012074966A3 Improved production of anti-peptide antibodies
10/26/2012WO2012073048A3 Variants of ignar
10/26/2012WO2012060572A9 Cloning and base sequence determination of novel iturin biosynthesis gene from antagonistic microorganism bacillus subtilis and characteristics of the gene
10/26/2012WO2012028525A3 Method for producing a tetranectin-apolipoprotein a-i particle, the lipid particle obtained therewith and its use
10/26/2012WO2007042166A8 Egln2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases
10/26/2012CA2833870A1 Adeno-associated virus virions with variant capsid and methods of use thereof
10/26/2012CA2833800A1 Methods and means to produce abiotic stress tolerant plants
10/26/2012CA2833756A1 Filamentous fungi having an altered viscosity phenotype
10/26/2012CA2833747A1 Endoglin polypeptides and uses thereof
10/26/2012CA2833668A1 Novel hypoallergens
10/26/2012CA2833660A1 Filamentous fungi having an altered viscosity phenotype
10/26/2012CA2833631A1 Novel process for the preparation of a virus-inactivated fv concentrate starting from human plasma, scalable to industrial level
10/26/2012CA2833623A1 Aav mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity
10/26/2012CA2833614A1 Locally-active anticoagulants and anti-inflammatory agents
10/26/2012CA2833541A1 Filamentous fungi having an altered viscosity phenotype
10/26/2012CA2833539A1 Filamentous fungi having an altered viscosity phenotype
10/26/2012CA2833434A1 Growth hormone releasing factor (grf) analogs and uses thereof
10/26/2012CA2833312A1 Yeast cell capable of converting sugars including arabinose and xylose
10/26/2012CA2833173A1 Beta-2 microglobulin-deficient cells
10/26/2012CA2833083A1 Down-regulating gene expression in insect pests
10/26/2012CA2833081A1 Hypoallergen
10/26/2012CA2832961A1 Plants having one or more enhanced yield-related traits and method for making the same
10/26/2012CA2832712A1 Compositions relating to a mutant clostridium difficile toxin and methods thereof
10/26/2012CA2832698A1 Plants having enhanced yield-related traits and method for making the same
10/26/2012CA2832638A1 Plants resistant to insect pests
10/26/2012CA2832152A1 Anticancer fusion protein
10/26/2012CA2831974A1 Methods for isolating and quantifying antigen from vaccines
10/25/2012US20120272409 Rock2 and Rock3, Two New Gain-of-Function Variants of the Cytokinin Receptors AHK2 and AHK3
10/25/2012US20120272404 Isolated nucleic acid molecule, genic construct, vector, transgenic cell, method of obtaining a cell and a transgenic plant, isolated and purified polypeptide, biodegradable pesticide composition, method of controlling a pest, method of obtaining transgenic strains resistant to an insect pest
10/25/2012US20120272403 Genetic transformation of jatropha curcas
10/25/2012US20120272393 Plants and seeds of corn variety cv240831
10/25/2012US20120272390 Plants and seeds of corn variety cv851732
10/25/2012US20120272384 Plants and seeds of corn variety cv606894
10/25/2012US20120272381 Plants and seeds of corn variety cv691958
10/25/2012US20120272369 Plants and seeds of hybrid corn variety ch332645
10/25/2012US20120272368 Plants and seeds of hybrid corn variety ch146292
10/25/2012US20120272365 Plants and seeds of hybrid corn variety ch784195
10/25/2012US20120272363 Plants and seeds of corn variety cv700979
10/25/2012US20120272354 Plants and seeds of hybrid corn variety ch481662
10/25/2012US20120271124 Thrombospondin Fragments and Uses Thereof In Clinical Assays for Cancer and Generation of Antibodies and Other Binding Agents
10/25/2012US20120271042 Method for isolation of genomic dna, rna and proteins from a single sample
10/25/2012US20120271041 Production of glycoproteins with low n-glycolylneuraminic acid (neu5gc) content
10/25/2012US20120271040 Mammalian expression vector
10/25/2012US20120271039 Method for purifying active gla-domain coagulation proteins
10/25/2012US20120271038 Extraction of proteins by a two solvent method
10/25/2012US20120271036 Solution Assay and High Through-Put Screen to Probe Interaction Between Human Cullin-Ring Ligase Complex and HIV-VIF Protein
10/25/2012US20120271035 T1r taste receptors and genes encoding same
10/25/2012US20120271033 High affinity adaptor molecules for redirecting antibody specifity
10/25/2012US20120270948 Polymorphisims in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications
10/25/2012US20120270938 Small molecules that covalently modify transthyretin
10/25/2012US20120270811 Conformations of divergent peptides with mineral binding affinity
10/25/2012US20120270810 Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices
10/25/2012US20120270809 Human transmembrane proteins
10/25/2012US20120270808 Compositions and methods related to synchronous selection of homing peptides for multiple tissues by in vivo phage display
10/25/2012US20120270802 Binding molecules for the treatment of myeloid cell malignancies
10/25/2012US20120270801 Her3 binding polypeptides
10/25/2012US20120270800 Bifunctional stapled polypeptides and uses thereof
10/25/2012US20120270792 Urocortin-iii and uses thereof
10/25/2012US20120270789 Treatment of coagulopathy with hyperfibrinolysis
10/25/2012US20120270788 Method of Administering Porcine B-Domainless fVIII
10/25/2012US20120270787 Compounds having peptides conjugated to bone targeting moieties and methods of making and using thereof
10/25/2012US20120270784 Growth hormone releasing factor (grf) analogs and uses thereof
10/25/2012US20120270781 Expression Vectors and Cell Lines Expressing Vascular Endothelial Growth Factor D, and Method of Treating Melanomas
10/25/2012US20120270776 Novel pesticidal toxins
10/25/2012US20120270773 Trim5alpha mutants and uses thereof
10/25/2012US20120270301 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species
10/25/2012US20120270296 Isotope-doped nano-structure and isotope labeled structure using the smae
10/25/2012US20120270290 Pentose transporter
10/25/2012US20120270266 Nucleic ac1d and amino ac1d sequences encoding high-level expressor factor viii polypeptides and methods of use
10/25/2012US20120270254 Method for analyzing secretome, biomarker for lung cancer metastasis, and sirna compound for inhibiting lung cancer metastasis
10/25/2012US20120270234 Ddr2 protein with activated kinase activity and preparation method thereof
10/25/2012US20120270232 Characterization of granulocytic ehrlichia and methods of use
10/25/2012US20120270230 Mutant g-protein coupled receptors and methods for selecting them
10/25/2012US20120270219 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
10/25/2012US20120270208 Synthetic antigens for the detection of antibodies to hepatitis c virus
10/25/2012US20120269948 Canola protein product from supernatant
10/25/2012US20120269885 Vaccine for Modulating Between T1 and T2 Immune Responses
10/25/2012US20120269884 Vaccine for Modulating Between T1 and T2 Immune Responses
10/25/2012US20120269859 Multimer of extracellular domain of cell surface functional molecule
10/25/2012US20120269858 Polypeptides
10/25/2012US20120269856 Stable immunogenic protein having multiple cysteines molecules process therefor and composition thereof
10/25/2012US20120269855 Toll-like receptor 5 ligands and methods of use
10/25/2012US20120269854 Method of Enhancing KSHV LANA1 Immunogenicity
10/25/2012US20120269851 Expression cassettes endcoding hiv-1 south african subtype c modified proteins
10/25/2012US20120269843 S. epidermidis antigens
10/25/2012US20120269841 Compositions relating to a mutant clostridium difficile toxin and methods thereof
10/25/2012US20120269840 Expression of hiv polypeptides and production of virus-like particles
10/25/2012US20120269837 SUBSTANCE BINDING HUMAN IgG Fc RECEPTOR IIb (FcgammaRIIb)
10/25/2012US20120269835 Process for the production of immunogenic compositions
10/25/2012US20120269830 Conjugates with improved pharmacokinetic properties
10/25/2012US20120269765 Cytokine compositions and methods of use thereof
10/25/2012US20120269764 RBM3 as a Marker for Malignant Melanoma Prognosis
10/25/2012DE102008049136B4 Neue Regulatoren des angeborenen Immunsystems New regulators of the innate immune system
10/24/2012EP2514825A2 Disease resistant plants
10/24/2012EP2514821A1 Cystatin c, beta2 microglobulin, alpha1 microglobulin and genes for same, antibody, and kit and method for diagnosis of feline nephropathy
10/24/2012EP2514768A1 Fusion polypeptide against eb virus-induced tumor and colicin ia mutant
10/24/2012EP2514763A1 Egf receptor epitope peptides and uses thereof
10/24/2012EP2514762A2 B7-DC variants
10/24/2012EP2514761A1 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof
1 ... 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 ... 2916